Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swiss Advanced Vision (SAV-IOL) is a Swiss medical technology company that develops, manufactures, and markets innovative intraocular lenses (IOLs) for cataract surgery. The company is known for its patented 'Instant Focus' technology, which provides an extended depth of focus (EDOF) to restore continuous vision from near to intermediate distances. Its product portfolio includes the InFo, Lucidis, Eden, and Harmonis lenses, which cater to various patient needs from affordable to premium and customizable solutions. SAV-IOL is also developing R-TASC, a smart active intraocular lens with real-time autofocus capabilities. Headquartered in Neuchâtel, the company distributes its products in over 40 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swiss Advanced Vision.